BAA eetwp 65 - community uses of psychedelics and safety study (cups)
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40122C00116
- Awardee
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518 Part of State Of California Controllers Office
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,589,446
Award facts
- Opportunity
-
- FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2200123 · Posted Nov 10, 2021
- Contract value 97% obligated
-
- $3,589,446.34 Current, with exercised options
- $3,701,150.34 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 165 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Francisco, CA 94103, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $919,016 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,916,457 | |
| Other Administrative Action | $0 | |
| Original award | $753,973 |
About this award
This is a $3,701,150.34 federal contract awarded by the Food and Drug Administration (FDA) to The Regents of the University of California, San Francisco (UCSF) for the "Community Uses of Psychedelics and Safety Study" (CUPS). The contract has a period of performance ending on March 30, 2026 and is a definitive, firm-fixed price contract with no set-aside designation.
The contract supports research to assess emerging trends of harm and establish safety methods for psychedelic use in community settings. Key aspects include data collection from electronic health records in Oregon to investigate the association of regulatory changes with psilocybin-related adverse outcomes. UCSF is collaborating with subcontractors Oregon Health & Science University, Legacy Emanuel Hospital & Health Center, and Kaiser Foundation Hospitals on the data collection and analysis efforts.
This contract award is part of the FDA's broader Broad Agency Announcement soliciting research and development proposals to advance regulatory science across multiple domains. The research aims to support the FDA's mission of protecting and promoting public health.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Legacy Emanuel Hospital & Health Center | $70,125 | |
| Oregon Health & Science University | $66,865 | |
| Legacy Emanuel Hospital & Health Center | $75,057 | |
| Kaiser Foundation Hospitals | $100,821 |
Quick answers
Who was awarded contract 75F40122C00116?
75F40122C00116 was awarded to The Regents Of The University Of California. San Francisco by Food and Drug Administration (Department of Health and Human Services) on September 22, 2022.
How much is contract 75F40122C00116 worth?
The government has obligated $3,589,446 on 75F40122C00116. Its potential value, with all options, is $3,701,150.
Was contract 75F40122C00116 competed?
The extent of competition for 75F40122C00116 was full and open competition. The government received 165 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award